EUVIMEDEUVIMED entdecken
Crossref

Sleep Related Breathing Disorders in Patients With MuSK Myasthenia Gravis, Compared to MuSK Negative Myasthenia Gravis

Bradley V Vaughn iD, Shakeel Tabish, James F Howard iD

Muscle & Nerve · 14.11.2026

DOI: 10.1002/mus.70455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 14.11.2026. Verfasst von Bradley V Vaughn und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sleep Medicine Division Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Autoimmune Myasthenia Gravis (MG) is associated with obstructive sleep apnea. Muscle‐specific kinase antibody positive MG (MuSK‐ab+ gMG) patients often have more bulbar weakness than MuSK antibody negative (MuSK‐ab‐) patients, but data comparing sleep‐related breathing disorders is scarce.

Methods

Utilizing the University of North Carolina Myasthenia Gravis Registry, 30 MuSK‐ab+ generalized MG (gMG) patients (26 female, 4 male) were matched with 30 MuSK‐ab− gMG patients for age, sex, and Myasthenia Gravis Foundation of America (MGFA) clinical class. Additionally, 30 MuSK‐ab− ocular MG patients were matched for age and sex. Features of sleep‐related symptoms, sleep diagnosis, polysomnogram findings, need for positive airway pressure (PAP) and chronic nocturnal supplemental oxygen were analyzed. Statistical significance was determined using Chi‐square test with 95% confidence intervals and Student T test ( p < 0.05).

Results

MuSK‐ab+ MG patients had a higher prevalence of sleep related breathing disorders than the two comparative groups (Odds Ratio [Confidence Interval] 4.97 [1.39–17.82], 3.82 [1.15–12.71], respectively) and for obstructive sleep apnea in MuSK‐ab+ gMG vs. MuSK‐ab− gMG (4.33 [1.20–15.61]). MuSK‐ab+ patients had higher rates of sleep related hypoventilation than MuSK‐ab− groups (8.8 [1.01–76.96], 19.46 [2.18–2574]) and requirement for bilevel PAP and nocturnal supplemental oxygen (Odds ratio for both groups, 23.04 [2.63–3037], 23.0 [2.63–3037]).

Discussion

Our cohort suggests MuSK‐ab+ patients are more likely to have sleep‐related breathing disorders independent of MGFA class, age, and sex. Given the long‐term health risks of sleep‐related breathing disorders, we suggest clinicians perform routine sleep screening with a low threshold for in‐laboratory polysomnography.

Schlagwörter

Stichwörter der Autor:innen

AChR‐ab+MuSK‐ab+hypoventilationhypoxemiainsomniamyasthenia gravissleepsleep apnea

Autor:innen und Institutionen

  • Sleep Medicine Division Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Trinity Health, University of North Dakota, Minot, North Dakota, USA.
  • Neuromuscular Disorders Division, Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

ORCID-Profile: Bradley V Vaughn, James F Howard

Zitieren

APA

Vaughn, B. V., Tabish, S., & Howard, J. F. (2026). Sleep Related Breathing Disorders in Patients With MuSK Myasthenia Gravis, Compared to MuSK Negative Myasthenia Gravis. Muscle & Nerve. https://doi.org/10.1002/mus.70455

Vancouver

Vaughn BV, Tabish S, Howard JF. Sleep Related Breathing Disorders in Patients With MuSK Myasthenia Gravis, Compared to MuSK Negative Myasthenia Gravis. Muscle & Nerve. 2026. doi:10.1002/mus.70455

BibTeX
@article{Vaughn2026,
  author = {Vaughn, Bradley V and Tabish, Shakeel and Howard, James F},
  title = {Sleep Related Breathing Disorders in Patients With MuSK Myasthenia Gravis, Compared to MuSK Negative Myasthenia Gravis},
  journal = {Muscle & Nerve},
  year = {2026},
  doi = {10.1002/mus.70455}
}
Kostenlos starten →